Modulation of nuclear factor-kappa B activity can influence the susceptibility to systemic lupus erythematosus
dc.contributor.author | Kalergis, Alexis M. | |
dc.contributor.author | Iruretagoyena, Mirentxu I. | |
dc.contributor.author | Barrientos, Magaly J. | |
dc.contributor.author | Gonzalez, Pablo A. | |
dc.contributor.author | Herrada, Andres A. | |
dc.contributor.author | Leiva, Eduardo D. | |
dc.contributor.author | Gutierrez, Miguel A. | |
dc.contributor.author | Riedel, Claudia A. | |
dc.contributor.author | Bueno, Susan M. | |
dc.contributor.author | Jacobelli, Sergio H. | |
dc.date.accessioned | 2024-01-10T12:06:44Z | |
dc.date.available | 2024-01-10T12:06:44Z | |
dc.date.issued | 2009 | |
dc.description.abstract | P>Autoimmune diseases, such as systemic lupus erythematosus (SLE), result from deficiencies in self-antigen tolerance processes, which require regulated dendritic cell (DC) function. In this study we evaluated the phenotype of DCs during the onset of SLE in a mouse model, in which deletion of the inhibitory receptor Fc gamma RIIb leads to the production of anti-nuclear antibodies and glomerulonephritis. Splenic DCs from Fc gamma RIIb-deficient mice suffering from SLE showed increased expression of co-stimulatory molecules. Furthermore, diseased mice showed an altered function of the nuclear factor-kappa B (NF-kappa B) transcription factor, which is involved in DC maturation. Compared with healthy animals, expression of the inhibitory molecule I kappa B-alpha was significantly decreased in mice suffering from SLE. Consistently, pharmacological inhibition of NF-kappa B activity in Fc gamma RIIb-deficient mice led to reduced susceptibility to SLE and prevented symptoms, such as anti-nuclear antibodies and kidney damage. Our data suggest that the occurrence of SLE is significantly influenced by alterations of NF-kappa B function, which can be considered as a new therapeutic target for this disease. | |
dc.description.funder | FONDECYT | |
dc.description.funder | Proyecto | |
dc.description.funder | FONDEF | |
dc.description.funder | Millennium Nucleus on Immunology and Immunotherapy | |
dc.description.funder | VRAID | |
dc.description.funder | CONICYT | |
dc.fechaingreso.objetodigital | 2024-05-07 | |
dc.format.extent | 9 páginas | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1111/j.1365-2567.2008.02964.x | |
dc.identifier.issn | 0019-2805 | |
dc.identifier.pubmedid | MEDLINE:19016912 | |
dc.identifier.uri | https://doi.org/10.1111/j.1365-2567.2008.02964.x | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/76201 | |
dc.identifier.wosid | WOS:000268703800015 | |
dc.information.autoruc | Ciencias Biológicas;Bueno SM;S/I;113541 | |
dc.information.autoruc | Ciencias Biológicas;González PA;S/I;15616 | |
dc.information.autoruc | Medicina;Gutiérrez MA;S/I;68377 | |
dc.information.autoruc | Ciencias Biológicas;Herrada AA;S/I;174374 | |
dc.information.autoruc | Medicina;Iacobelli SH;S/I;98345 | |
dc.information.autoruc | Medicina;Iruretagoyena MI;S/I;144496 | |
dc.information.autoruc | Ciencias Biológicas;Kalergis AM;S/I;90610 | |
dc.information.autoruc | Ciencias Biológicas;Leiva ED;S/I;142382 | |
dc.issue.numero | 1 | |
dc.language.iso | en | |
dc.nota.acceso | contenido parcial | |
dc.publisher | WILEY-BLACKWELL PUBLISHING, INC | |
dc.revista | IMMUNOLOGY | |
dc.rights | acceso restringido | |
dc.subject | andrographolide | |
dc.subject | autoimmunity | |
dc.subject | dendritic cells | |
dc.subject | nuclear factor-kappa B | |
dc.subject | rosiglitazone | |
dc.subject | systemic lupus erythematosus | |
dc.subject | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | |
dc.subject | PLASMACYTOID DENDRITIC CELLS | |
dc.subject | T-CELLS | |
dc.subject | ANDROGRAPHIS-PANICULATA | |
dc.subject | ANTIGEN PRESENTATION | |
dc.subject | GAMMA | |
dc.subject | ACTIVATION | |
dc.subject | INHIBITION | |
dc.subject | DISEASE | |
dc.subject | ALPHA | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Modulation of nuclear factor-kappa B activity can influence the susceptibility to systemic lupus erythematosus | |
dc.type | artículo | |
dc.volumen | 128 | |
sipa.codpersvinculados | 113541 | |
sipa.codpersvinculados | 15616 | |
sipa.codpersvinculados | 68377 | |
sipa.codpersvinculados | 174374 | |
sipa.codpersvinculados | 98345 | |
sipa.codpersvinculados | 144496 | |
sipa.codpersvinculados | 90610 | |
sipa.codpersvinculados | 142382 | |
sipa.index | WOS | |
sipa.index | Scopus | |
sipa.trazabilidad | Carga SIPA;09-01-2024 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Modulation of nuclear factor-kappa B activity can influence the susceptibility to systemic lupus erythematosus.pdf
- Size:
- 3.19 KB
- Format:
- Adobe Portable Document Format
- Description: